|
CERCA |
|
|
inserisci una parola: |
|
| |
|
|
| |
|
|
|
 |
PRINCIPLES AND PRACTICE OF LUNG CANCER |
 |
|
|
Prezzo*: € 0,00
|
|
Siamo spiacenti, il prodotto non è al momento disponibile.
Richiedi avviso
|
|
*Il prezzo si intende IVA inclusa
Descrizione
Principles and Practice of Lung Cancer The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC)
- Autor (s): Harvey I Pass MD, David P Carbone MD, PhD David H Johnson MD, John D Minna MD, Giorgio V Scagliotti MD, Andrew T Turrisi III MD
- Edition: Fourth
- Product Format: Softbound
- ISBN: 9780781773652
- Trim Size: 8.375 x 10.875
- Pages: 1040
- Pub Date: 15, Apr 2010
Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. This edition has expanded thoracic oncology chapters including thymus, mesothelioma, and mediastinal tumors, more detailed discussion of targeted agents, and state-of-the-art information on newer techniques in radiotherapy. Other highlights include more international contributors and greater discussion of changes in lung cancer management in each region of the world. A new editor, Giorgio Scagliotti, MD from the University of Turin, has coordinated the accounts of European activities. A companion website includes the full text online and an image bank.
--NEW! Continued and expanded Thoracic Oncology chapters including Thymus, Mesothelioma, Mediastinal Tumors --NEW! More detailed discussion of targeted agents --NEW! More detailed discussion of newer techniques in radiotherapy for lung cancer --NEW! Addition of Italian editor, Giorgio Scagliotti, MD, who will coordinate European activities of the book --NEW! More international authors --NEW! More pro/con discussion with changes in management discussion by continent --NEW! Now the official reference text of the International Association for the Study of Lung Cancer (IASLC) --The most comprehensive lung cancer book available in the market --Stresses combined modality treatments for small cell and non-small cell lung cancer, as well as the management of metastases and the complications of treatment --Contributor base reflects world authorities in this field
Harvey I Pass MD
Professor of Surgery and Oncology, Aerodigestive Program Director, Karmanos Cancer Institute, Wayne State University, Detroit, MI
David P Carbone MD, PhD
Professor of Medicine and Cancer Biology, Ingram Professor and Director, Experimental Therapeutics Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
David H Johnson MD
Cornelius A. Craig Professor of Medical Oncology, Director, Division of Hematology/Oncology, Deputy Director, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
John D Minna MD
Professor, Internal Medicine and Pharmacology, Director, Harmon Center for Therapeutic Oncology Research, Director, Moncrief Center for Cancer Genetics, Sara M. and Charles E. Seay Distinguished Chair for Cancer Research, Max L. Thomas Distin
Giorgio V Scagliotti MD
Department of Clinical and Biological Sciences, University of Turin; Head, Thoracic Oncology Unit, S. Luigi Hospital, Turin, Italy
Andrew T Turrisi III, MD
Professor and Chair, Department of Radiation Oncology, Wayne State University; Radiation Oncologist-in-Chief, Detroit Medical Center; Chief, Radiation Oncology, Karmanos Cancer Center, Wayne State University / Karmanos, Detroit, MI
PLUNG CANCER EPIDEMIOLOGY:
The Etiology & Epidemiology of Lung Cancer
The Tobacco Epidemic
Nontobacco-Related Lung Carcinogenesis
Genetic Susceptibility to Lung Cancer
LUNG CANCER BIOLOGY:
An Overview of the Molecular Biology of Lung Cancer
Genomic Alterations in Lung Cancer
Epigenetic Changes in Lung Cancer: Pathobiological & Clinical Aspects
Molecular Events Surrounding the Angiogenic Switch of Lung Cancer
Applications of Proteomics to Management of Lung Cancer
Molecular Prognostication of Lung Cancer
Examining the Cancer Stem Cell Hypothesis in Human Lung Cancers
Lung Cancer & Its Microenvironment
Mouse Models of Lung Cancer
Cell Cycle & Vascular Targets for Radiotherapy
SCREENING & PREVENTION:
Population-Based Lung Cancer Prevention: An Overview
Screening for Lung Cancer
Low-Dose CT Screening: Experiences from the Randomized Population-Based Nelson Screening Trial
Fine-Needle Aspiration Cytology of Benign & Malignant Tumors of the Lung
Early Detection of Lung Cancer Using Bronchoscopy
Evolving Early Detection Modalities in Lung Cancer Screening
Molecular Carcinogenesis & Chemoprevention of Lung Cancer
PATHOLOGY: Molecular & Cellular Pathology of Lung Cancer
PRESENTATION, DIAGNOSIS & STAGING:
Clinical Presentation of Non-Small Cell Carcinoma of the Lung
Clinical Presentation of Small Cell Lung Cancer
Gender-Related Differences in Lung Cancer
Conventional Imaging of Non-Small Cell Lung Cancer
PET in Lung Cancer
Bronchoscopy in Diagnosis & Evaluation of Lung Cancer
Surgical Evaluation of the Mediastinum
The International Staging System for Lung Cancer
SURGICAL MANAGEMENT OF LUNG CANCER:
Minimally Invasive Techniques for Management of Lung Cancer
Extent of Resection for Stage I Lung Cancer
Management of Ground-Glass Opacity Lesions
Management of Stage II Non-Small Cell Lung Cancer & Pancoast Tumors
Vertebral Body Resection
Surgical Management of Second Primary & Metastatic Lung Cancer
Percutaneous Therapeutic Technologies for Medically Inoperable Lung Cancer
Surgical Management of Small Cell Lung Cancer
Complications of Surgery for Lung Cancer
RADIATION THERAPY & LUNG CANCER: Physical Basis of Modern Radiotherapy: Dose & Volume
Biological Basis of Fractionation & Timing of Radiotherapy
Radiotherapy for Locally Advanced Lung Cancer: Stages IIIA & IIIB
Stereotactic Techniques for Lung Cancer Treatment
Radiation Treatment-Related Lung Damage
CHEMOTHERAPY & LUNG CANCER:
Chemotherapy for Advanced Non-Small Cell Lung Cancer
Chemotherapy for Recurrent or Refractory Advanced Non-Small Cell Lung Cancer
Pharmacogenomics in Lung Cancer: Predictive Biomarkers for Chemotherapy
NOVEL TARGETED AGENTS & LUNG CANCER:
Antiangiogenic Agents
Anti-EGFR Therapies: How to Select Patients
Other Signal Transduction Agents
Lung Cancer Vaccines
Targeted Therapies & Radiation in Lung Cancer
ADJUVANT & NEOADJUVANT APPROACHES FOR NON-SMALL CELL LUNG CANCER:
Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer
Preoperative Chemotherapy for Early-Stage Non-Small Cell Lung Cancer
Preoperative Chemotherapy
Radiation Therapy for Early-Stage & Locally Advanced Non-Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer
Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer
TREATMENT OF SMALL CELL LUNG CANCER:
Chemotherapy for Small Cell Lung Cancer
Multimodality Therapy for Limited-Stage Small Cell Lung Cancer: Combining Chemotherapy & Radiotherapy
Prophylactic Cranial Irradiation in Small Cell Lung Cancer
LUNG CANCER EMERGENCIES:
Endoscopic Ablational Therapies & Stenting
Management of Malignant Pleural Effusion
Management of Overt Central Nervous System Metastases: Brain & Spinal Cord
OTHER THORACIC MALIGNANCIES:
Thymoma & Thymic Carcinoma
Malignant Mesothelioma
Management of Mediastinal Tumors Not of Thymic Origin
The Spectrum of Carcinoid Tumors
Torna alla homepage
|
|
 |
Login |
 |
|
|
|
|
NEWSLETTER |
|
|
inserisci la tua email: |
|
| |
|
|
| |
|
|
|
|
Novità |
|
|
|
|
|
|
|
|
|
